Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ErbB2 (HER2) is a receptor tyrosine kinase belonging to the ErbB family. It lacks a known direct ligand and primarily functions as a dimerization partner for other ErbB receptors, activating downstream signaling pathways that regulate cell proliferation, survival, and other cellular processes. Overexpression or amplification of HER2 is implicated in various cancers, particularly breast and gastric cancer, making it an important therapeutic target and biomarker.
Tyrosine kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ErbB2 Receptor Tyrosine Kinase (HER2).